Pancreatic Cancer Research

ResearcherFudan UniversityActive in the last 2 years

Fang Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5971-2622; OpenAlex author ID A5029787563. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2026: 4 papers

Papers 4

  1. PROK1 Induces Macrophage M2 Phenotype Conversion to Promote Pancreatic Cancer Progression by Activating the PI3K/AKT Pathway Via Interacting with PROKR2. Last author DOI 10.1007/s12010-026-05772-0↗
  2. Role of PTK6 in the diagnosis, prognosis, and immune infiltration of pancreatic cancer based on evidence from bioinformatics analysis and experimental validati… Co-author DOI 10.1007/s12672-026-05115-9↗
  3. Identification of a Novel AT1R-Targeted Near-Infrared Fluorescent Probe for Visualization and Imaging-Guided Surgery in Pancreatic Cancer. Co-author DOI 10.1021/acs.analchem.6c00740↗
  4. Alisertib Induces Cell Cycle Arrest and Autophagy and Suppresses Epithelial-to-Mesenchymal Transition Involving PI3K/Akt/mTOR and Sirtuin 1-Mediated signaling … Co-author DOI 10.2147/dddt.s633636↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shu-Lin Yu · 1 shared paper, 2026 · strength 0.36
  2. Yue Fan · 1 shared paper, 2026 · strength 0.36
  3. Peiwen Yang · 1 shared paper, 2026 · strength 0.36
  4. Juying Jiao · 1 shared paper, 2026 · strength 0.36
  5. Lan Ma · 1 shared paper, 2026 · strength 0.32
  6. Jianjun Song · 1 shared paper, 2026 · strength 0.32
  7. Yongfeng Hui · 1 shared paper, 2026 · strength 0.32
  8. Shu-Feng S Zhou · 1 shared paper, 2026 · strength 0.26
  9. Jin Zhu · 1 shared paper, 2026 · strength 0.26
  10. Yuanbiao Tu · 1 shared paper, 2026 · strength 0.26
  11. Ray P. S. Han · 1 shared paper, 2026 · strength 0.26
  12. Li Wang · 1 shared paper, 2026 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.